Molecular profiling differentiates IDH-wildtype grade 4 astrocytomas (known as glioblastomas) from IDH-mutant, WHO grade 4 astrocytomas, which were historically labeled as ‘secondary glioblastomas’. Here, IDH1 is linked to glioblastoma.